期刊文献+

Apolipoprotein E Guangzhou(arginine 150proline):一种新的脂蛋白肾病相关的基因突变 被引量:3

Apofipoprotein E Guangzhou (argininel50 proline): a new variant in fipoprotein glomerulopathy
原文传递
导出
摘要 目的通过分析1个包含4个脂蛋白肾病患者的家系所有成员的载脂蛋白E(apoE)基因,寻找脂蛋白肾病相关的apoE基因突变。方法收集该家系全部成员的病史,所有成员进行尿常规、血肌酐、血脂、血清脂蛋白检查。抽提基因组DNA,PCR法扩增所有成员的apoE第4外显子。割胶纯化PCR产物后直接测序,并将纯化的PCR产物亚克隆至pMD18-T载体,挑菌落测序。结果4例脂蛋白肾病患者和1例无症状直系亲属均携带一种新的apoE点突变的杂合子,150号密码子发生点突变:CGC→CCC(由精氨酸变成脯氨酸),伴有血浆apoE的升高。结论apoE点突变apoE Guangzhou(arginine 150 proline)可能是该家系脂蛋白肾病发病的原因。 Objective To investigate the pathogenesis of lipoprotein glomerulopathy (LPG) by analyzing the apolipoprotein E (apoE) gene of members in a family including four LPG patients and one asymptomatic carrier. Methods Laboratory tests for urinalysis, serum creatinine, plasma lipid and lipoprotein were performed on all the members of above family. Genomic DNA was extracted from peripheral leukocytes. The fragment of the apoE gene covering exon 4 was amplified by PCR. The gel-purified PCR products were directly sequenced and subcloned into the pMD 18-T vector. Recombinant plasmids were sequenced to investigate both alleles of patients. Results A nucleotide G to C point mutation in exon 4 of the apoE gene was confirmed in each patient and one asymptomatic member. This missense mutation encoded a new apoE variant that amino acid substitution of the proline residue for arginine residue at position 150 of apoE. Those carriers were all heterozygous of this novel point mutation apoE(argininelS0 proline) with elevated plasma concentrations of apoE. Conclusions A new variant of apoE, apoE (argininel50 proline), has been identified in a family with 3 generations, including four LPG patients and one asymptomatic carrier. Study of this variant characteristics may be important for understanding the pathogenesis of LPG.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2007年第11期711-715,共5页 Chinese Journal of Nephrology
关键词 载脂蛋白E类 点突变 系谱 脂蛋白肾病 Apolipoproteins E Point mutation Pedigree Lipoprotein glomerulopathy
  • 相关文献

参考文献5

二级参考文献29

  • 1ZHANGBo,LIUZhi-hong,ZENGCai-hong,ZHENGJing-min,CHENHui-ping,ZHOUHong,LILei-shi.Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy[J].Chinese Medical Journal,2005(7):555-560. 被引量:8
  • 2陈惠萍,黎磊石.脂蛋白肾小球病[J].肾脏病与透析肾移植杂志,1997,6(2):182-184. 被引量:20
  • 3Sakaguchi H, Mitarai T, Hirose S, et al. Lipoprotein glomerulopathy-a new disease with specific histological findings. Jpn J Nephrol, 1989, 31:451-456.
  • 4Saito T, Sato H, Oikawa S, et al. Lipoprotein glomerulopathy:report of a normolipidemic case and review of the literature. Am J Nephrol, 1993, 13: 64-68.
  • 5Meyrier A, Dairou F, Callard P, et al. Lipoprotein glomerulopathy: First case in a white European. Nephrol Dial Transplant, 1995, 10: 546-549.
  • 6Mourad G, Djamali A, Turc-Baron C, et al. Lipoprotein glomerulopathy: A new cause of nephrotic syndrome after renal transplantation. Nephrol Dial Transplant, 1998, 13: 1291-1294.
  • 7Zhang P, Matalon R, Kaplan L, et al. Lipoprotein glomerulopathy: first report in a Chinese male. Am J Kidney Dis,1994, 24: 942-950.
  • 8Oikawa S, Suzuki N, Sakuma E, et al. Abnormal lipoprotein and apolipoprotein pattern in lipoprotein glomerulopathy. Am J Kidney Dis, 1991, 18: 553-558.
  • 9Saito T, Oikawa S, Sato H, et al. Lipoprotein glomerulopathy:renal lipidosis induced by novel apolipoprotein E variants.Nephron, 1999, 83: 193-201.
  • 10Faraggiana T, Churg J. Renal lipidosis: a review. Hum Pathol,1987, 18:661-679.

共引文献45

同被引文献70

  • 1陈燕,王庆文.全血脂蛋白吸附治疗脂蛋白肾病[J].肾脏病与透析肾移植杂志,2004,13(5):493-498. 被引量:13
  • 2陈姗,刘志红,郑敬民,张鑫,黎磊石.脂蛋白肾病患者载脂蛋白E基因全长序列分析[J].肾脏病与透析肾移植杂志,2005,14(3):218-223. 被引量:14
  • 3潘永利,陈育青,张宏,李侠,邢广群,师军华,侯平,王海燕.四例脂蛋白肾病患者载脂蛋白E基因突变筛查[J].中华肾脏病杂志,2006,22(8):449-453. 被引量:13
  • 4Saito T, Sato H, Kudo K, et al. Lipoprotein glomerulopathy:glomerular lipoprotein thrombi in a patient with hyperlipoproteinemia. Am J Kidney Dis, 1989, 13: 148-153.
  • 5Karube M, Nakabayashi K, Fujioka Y, et al. Lipoprotein glomerulopathy-like disease in a patient with type III hyperlipoproteinemia due to apolipoprotein E2. (Arg158 Cys)/3 heterozygosity. Clin Exp Nephrol, 2007, 11: 174-179.
  • 6Oikawa S, Matsunaga A, Saito T, et al. Apolipoprotein E Sendai (argi2 nine 145-proline) a new variant associated with lipop rotein glomelopathy. J Am Soc Nephrol, 1997, 8: 20-823.
  • 7Ishigaki Y, Oikawa S, Suzuki T, et al. Virus-mediated transduction of apolipoprotein & Sendai develops lipoprotein glomerulopathy in apoE deficientmice. J Biol Chem, 2000, 275 : 31,269- 231, 2731.
  • 8Matsunaga A, Sasaki J, Komatsu T, et al. A novel apolipop rotein E mutation, E2(Arg 25 Cys), in lipoprotein glomerulopathy. Kidney Int, 1999, 56:421-427.
  • 9Konishi K, Saruta T, Kuramochi S, et al. Association of a novel 3-amino acid deletion mutation of apolipop rotein E(apoE Tokyo) wity lipoprotein glomerulopahy. Nephron, 1999, 83: 214-218.
  • 10Ogawa T, Maruyama K, Hattori H, et al. A new variant of apolipoprotein E(apoE Maebashi) in lipoprotein glomerulopathy. Pediater Nephrol, 2000, 14: 149-151.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部